Betamethasone Dipropionate
Overview
Betamethasone Dipropionate is a potent synthetic glucocorticoid steroid with anti-inflammatory and immunosuppressant properties. It is commonly used in the treatment of skin conditions such as eczema, psoriasis, and dermatitis.
API suppliers (14)
Suppliers of Betamethasone Dipropionate evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 9 of 14 suppliers.
3 of 14 hold a GMP certificate on record in the EU or UK registers
- CURIA SPAIN SAUSpain1 active DMF GMP on record
- TAPI NL BVNetherlands1 active DMF
- TIANJIN TIANYAO PHARMACEUTICALS CO LTDChina1 active DMF
- HENAN LIHUA PHARMACEUTICAL CO LTD1 active DMF
- Taro Pharmaceutical Industries Ltd.Israel1 active DMF GMP on record
- HALCYON LABS PRIVATE LTDIndia1 active DMF
- FARMABIOS SPAItaly1 active DMF
- SYMBIOTICA SPECIALITY INGREDIENTS SDN BHDMalaysia1 active DMF
- SYMBIOTEC PHARMALAB PRIVATE LTDIndia1 active DMF GMP on record
- MAHIMA LIFE SCIENCES PRIVATE LTDIndia
- QUATRUM
- HOECHST MARION ROUSSEL SA
- COMPANIA ESPANOLA DE SINTESIS QUIMICA SA
- PHARMACIA AND UPJOHN SUB PFIZER INC
Patent & exclusivity (US)
Per the FDA Orange Book (28 approved US products), the latest listed US patent on Betamethasone Dipropionate expires 31 Aug 2030. Generic API sourcing typically opens up once these lapse.
Therapeutic areas
Do you supply Betamethasone Dipropionate? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.